Knowledge, perception and practice towards oxytocin stability and quality: A qualitative study of stakeholders in three resource-limited countries

Autor: Abebaw Minaye, Moti Tolera, Snigdha Verma, Victoria L. Oliver, Kyu Kyu Than, Yasmin Mohamed, Michelle P. McIntosh, Stanley Luchters, Alula M. Teklu, Vishwajeet Kumar, Ranjana Yadav, Peter Lambert
Rok vydání: 2018
Předmět:
Health Knowledge
Attitudes
Practice

Peptide Hormones
Health Care Providers
lcsh:Medicine
Myanmar
Oxytocin
Biochemistry
Geographical Locations
0302 clinical medicine
Drug Stability
Pregnancy
Health care
Urban Health Services
Medicine and Health Sciences
030212 general & internal medicine
Cold chain
lcsh:Science
Geographic Areas
Allied Health Care Professionals
2. Zero hunger
030219 obstetrics & reproductive medicine
Multidisciplinary
Geography
1. No poverty
Stakeholder
Neurochemistry
Focus Groups
3. Good health
Cold Temperature
Female
Neurochemicals
Thematic analysis
Research Article
Asia
Drug Storage
Supply chain
India
Cold storage
Interviews as Topic
03 medical and health sciences
Nursing
Humans
Developing Countries
business.industry
lcsh:R
Postpartum Hemorrhage
Biology and Life Sciences
Focus group
Hormones
Rural Areas
Health Care
Health Care Facilities
People and Places
Africa
Earth Sciences
lcsh:Q
Ethiopia
Rural Health Services
business
Neuroscience
Qualitative research
Zdroj: PLoS ONE
PLoS ONE, Vol 13, Iss 9, p e0203810 (2018)
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0203810
Popis: Background Oxytocin is the gold standard drug for the prevention of postpartum haemorrhage, but limitations in cold chain systems in resource-constrained settings can severely compromise the quality of oxytocin product available in these environments. This study investigated the perspectives and practices of stakeholders in low and lower-middle income countries towards oxytocin, its storage requirements and associated barriers, and the quality of product available. Methods Qualitative inquiries were undertaken in Ethiopia, India and Myanmar, where data was collected through Focus Group Discussions (FGDs) and In-Depth Interviews (IDIs). A total of 12 FGDs and 106 IDIs were conducted with 158 healthcare providers (pharmacists, midwives, nurses, doctors and obstetricians) and 40 key informants (supply chain experts, program managers and policy-makers). Direct observations of oxytocin storage practices and cold chain resources were conducted at 51 healthcare facilities. Verbatim transcripts of FGDs and IDIs were translated to English and analysed according to a thematic content analysis framework. Findings Stakeholder awareness of oxytocin heat sensitivity and the requirement for cold storage of the drug was widespread in Ethiopia but more limited in Myanmar and India. A consistent finding across all study regions was the significant barriers to maintaining a consistent cold chain, with the lack of refrigeration facilities and unreliability of electricity cited as major challenges. Perceptions of compromised oxytocin quality were expressed by some stakeholders in each country. Conclusion Knowledge of the heat sensitivity of oxytocin and the potential impacts of inconsistent cold storage on product quality is not widespread amongst healthcare providers, policy makers and supply chain experts in Myanmar, Ethiopia and India. Targeted training and advocacy messages are warranted to emphasise the importance of cold storage to maintain oxytocin quality.
Databáze: OpenAIRE